Found: 42
Select item for more details and to access through your institution.
Phenotypic diversity of circulating tumour cells in patients with metastatic castration-resistant prostate cancer.
- Published in:
- BJU International, 2017, v. 120, n. 5B, p. E30, doi. 10.1111/bju.13631
- By:
- Publication type:
- Article
Plasma androgen receptor and serum chromogranin A in advanced prostate cancer.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-33774-4
- By:
- Publication type:
- Article
Cost-utility analysis of adding abiraterone acetate plus prednisone/prednisolone to long-term hormone therapy in newly diagnosed advanced prostate cancer in England: Lifetime decision model based on STAMPEDE trial data.
- Published in:
- PLoS ONE, 2022, v. 17, n. 6, p. 1, doi. 10.1371/journal.pone.0269192
- By:
- Publication type:
- Article
The ReIMAGINE prostate cancer risk study protocol: A prospective cohort study in men with a suspicion of prostate cancer who are referred onto an MRI-based diagnostic pathway with donation of tissue, blood and urine for biomarker analyses.
- Published in:
- PLoS ONE, 2022, p. 1, doi. 10.1371/journal.pone.0259672
- By:
- Publication type:
- Article
Circulating Tumour DNA in Muscle-Invasive Bladder Cancer.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 9, p. 2568, doi. 10.3390/ijms19092568
- By:
- Publication type:
- Article
Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Circulating androgen receptor gene amplification and resistance to <sup>177</sup>Lu-PSMA-617 in metastatic castration-resistant prostate cancer: results of a Phase 2 trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Preclinical Evaluation of Imaging Biomarkers for Prostate Cancer Bone Metastasis and Response to Cabozantinib.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 4, p. 1, doi. 10.1093/jnci/dju033
- By:
- Publication type:
- Article
New horizons for prostate cancer: part 2.
- Published in:
- Trends in Urology & Men's Health, 2013, v. 4, n. 4, p. 13, doi. 10.1002/tre.339
- By:
- Publication type:
- Article
New horizons for prostate cancer: part 1.
- Published in:
- Trends in Urology & Men's Health, 2013, v. 4, n. 3, p. 38, doi. 10.1002/tre.334
- By:
- Publication type:
- Article
ABEMUS: platform-specific and data-informed detection of somatic SNVs in cfDNA.
- Published in:
- Bioinformatics, 2020, v. 36, n. 9, p. 2665, doi. 10.1093/bioinformatics/btaa016
- By:
- Publication type:
- Article
Phase I Study of Nintedanib Incorporating Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Patients With Advanced Solid Tumors.
- Published in:
- Oncologist, 2015, v. 20, n. 4, p. 368, doi. 10.1634/theoncologist.2014-0250
- By:
- Publication type:
- Article
Drivers of AR indifferent anti-androgen resistance in prostate cancer cells.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-50220-1
- By:
- Publication type:
- Article
Circulating Tumor Cells Count and Morphological Features in Breast, Colorectal and Prostate Cancer.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0067148
- By:
- Publication type:
- Article
Multi-Purpose Utility of Circulating Plasma DNA Testing in Patients with Advanced Cancers.
- Published in:
- PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0047020
- By:
- Publication type:
- Article
Unbiased and Automated Identification of a Circulating Tumour Cell Definition That Associates with Overall Survival.
- Published in:
- PLoS ONE, 2011, v. 6, n. 11, p. 1, doi. 10.1371/journal.pone.0027419
- By:
- Publication type:
- Article
A novel prostate cancer subtyping classifier based on luminal and basal phenotypes.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 14, p. 2169, doi. 10.1002/cncr.34790
- By:
- Publication type:
- Article
Advances in the management of high-risk localised and metastatic prostate cancer.
- Published in:
- BJU International, 2012, v. 109, p. 8, doi. 10.1111/j.1464-410X.2011.10871.x
- By:
- Publication type:
- Article
Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer.
- Published in:
- BJU International, 2009, v. 103, n. 9, p. 1256, doi. 10.1111/j.1464-410X.2008.08200.x
- By:
- Publication type:
- Article
Selective blockade of androgenic steroid synthesis by novel lyase inhibitors as a therapeutic strategy for treating metastatic prostate cancer.
- Published in:
- BJU International, 2005, v. 96, n. 9, p. 1241, doi. 10.1111/j.1464-410X.2005.05821.x
- By:
- Publication type:
- Article
Tumor clone dynamics in lethal prostate cancer.
- Published in:
- Science Translational Medicine, 2014, v. 6, n. 254, p. 1, doi. 10.1126/scitranslmed.3009448
- By:
- Publication type:
- Article
Identification of single nucleotide variants using position-specific error estimation in deep sequencing data.
- Published in:
- BMC Medical Genomics, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s12920-019-0557-9
- By:
- Publication type:
- Article
Simple prognostic score for metastatic castration-resistant prostate cancer with incorporation of neutrophil-to-lymphocyte ratio.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 21, p. 3346, doi. 10.1002/cncr.28890
- By:
- Publication type:
- Article
The CT flare response of metastatic bone disease in prostate cancer.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Clinical and biochemical consequences of CYP17A1 inhibition with abiraterone given with and without exogenous glucocorticoids in castrate men with advanced prostate cancer.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Genome-wide plasma DNA methylation features of metastatic prostate cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF SELECT consortium assay.
- Published in:
- NAR Cancer, 2022, v. 4, n. 2, p. 1, doi. 10.1093/narcan/zcac016
- By:
- Publication type:
- Article
Plasma DNA Analysis in Prostate Cancer: Opportunities for Improving Clinical Management.
- Published in:
- Clinical Chemistry, 2019, v. 65, n. 1, p. 100, doi. 10.1373/clinchem.2018.287250
- By:
- Publication type:
- Article
Integrating extracellular vesicle and circulating cell‐free DNA analysis using a single plasma aliquot improves the detection of HER2 positivity in breast cancer patients.
- Published in:
- Journal of Extracellular Biology, 2023, v. 2, n. 9, p. 1, doi. 10.1002/jex2.108
- By:
- Publication type:
- Article
Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Survival Outcomes in the STAMPEDE Randomized Controlled Trial.
- Published in:
- JNCI Cancer Spectrum, 2022, v. 6, n. 4, p. 1, doi. 10.1093/jncics/pkac043
- By:
- Publication type:
- Article
A step toward functionally characterized prostate cancer molecular subtypes.
- Published in:
- Nature Medicine, 2013, v. 19, n. 8, p. 966, doi. 10.1038/nm.3285
- By:
- Publication type:
- Article
Novel Strategies to Test Biological Hypotheses in Early Drug Development for Advanced Prostate Cancer.
- Published in:
- Clinical Chemistry, 2013, v. 59, n. 1, p. 75, doi. 10.1373/clinchem.2012.185157
- By:
- Publication type:
- Article
An open-label, multicenter, phase Ib study investigating the effect of apalutamide on ventricular repolarization in men with castration-resistant prostate cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476).
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 3, p. 422, doi. 10.1002/ijc.34018
- By:
- Publication type:
- Article
Plasma tumor DNA is associated with increased risk of venous thromboembolism in metastatic castration‐resistant cancer patients.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 7, p. 1166, doi. 10.1002/ijc.33834
- By:
- Publication type:
- Article
Visualizing whole-body treatment response heterogeneity using multi-parametric magnetic resonance imaging.
- Published in:
- Journal of Algorithms & Computational Technology, 2016, v. 10, n. 4, p. 290, doi. 10.1177/1748301816668024
- By:
- Publication type:
- Article
Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial.
- Published in:
- PLoS Medicine, 2022, v. 19, n. 6, p. 1, doi. 10.1371/journal.pmed.1003998
- By:
- Publication type:
- Article
Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A novel, spontaneously immortalized, human prostate cancer cell line, Bob, offers a unique model for pre-clinical prostate cancer studies.
- Published in:
- Prostate, 2009, v. 69, n. 14, p. 1507, doi. 10.1002/pros.20997
- By:
- Publication type:
- Article
Expression profiling of CD133<sup>+</sup> and CD133<sup>-</sup> epithelial cells from human prostate.
- Published in:
- Prostate, 2008, v. 68, n. 9, p. 1007, doi. 10.1002/pros.20765
- By:
- Publication type:
- Article
Sarcomatoid carcinoma of the prostate: ERG fluorescence in-situ hybridization confirms epithelial origin.
- Published in:
- Histopathology, 2015, v. 66, n. 6, p. 898, doi. 10.1111/his.12493
- By:
- Publication type:
- Article